Apologies if info on this has been posted before I couldn't find anything post July 2019.
I know this isn't as topical as COVID-19 (selfish i know, I don't have COVID-19 but do have disc issues) has anyone seen any information coming out of the MSB sponsored Phase 3 trial:
Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Subjects With Chronic Low Back Pain (MSB-DR003)
which was mooted as having: Estimated Primary Completion Date :March 2020
How long after primary completion would we expect results to be published?
Apologies if info on this has been posted before I couldn't find...
-
- There are more pages in this discussion • 16,148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.010(0.91%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.11 | $1.07 | $4.794M | 4.399M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14500 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 141676 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |